      |
| |
|
|
|
 |
| |
| |
BioLineRx’s founding partners represent the convergence
of venture capital, industry and academia, and include:
Teva Pharmaceuticals Industries
Ltd.
Teva, a global pharmaceutical company has its corporate headquarters
in Israel where the Company is the uncontested leader in the
production, sale and distribution of pharmaceutical products.
Teva has major manufacturing and marketing facilities in Israel,
North America and Europe. With more than a century of experience
in the healthcare industry, the Company enjoys a firmly established
international presence, operating through a carefully tailored
network of worldwide subsidiaries. In 2002, Teva posted an impressive
$2.5 billion in sales generating net income of $410 million.
With more than 10,500 employees and multiple international production
facilities at its disposal, the Company is poised to cultivate
and increase its strategic role as a major leader in the worldwide
pharmaceutical market.
www.tevapharma.com
Pitango Venture Capital
Pitango Venture Capital has been investing in technology entrepreneurs
since 1993. With offices in Israel, the Silicon Valley and London,
Pitango currently manages several venture funds totaling over
$700 million in committed capital invested in more than 85 companies
including AudioCodes (NASDAQ: AUDC), Chromatis (acquired by
Lucent), CardGuard (SWX New Market: CARDG), ITXC (NASDAQ: ITXC)
and Radware (NASDAQ: RDWR). Pitango specializes in providing
long-term support and value-added services to its portfolio
companies, with a focus on seed to late-stage companies in Communications,
Software and Internet Infrastructure, Semiconductors and Life-Sciences.
www.pitango.com
Giza Venture Capital
Giza Venture Capital was established in 1992 and has three funds
totaling $316 million. Giza has invested in 64 early to late-stage
companies in the sectors of Communications, IT, Enterprise Software
and Life-Sciences, with 21 exits including: Precise (NASDAQ:PRSE),
Oridion (SWX:ORIDN), Butterfly (acquired by TI), Libit (acquired
by TI), M- Systems (NASDAQ:FLSH), Zoran (NASDAQ:ZRAN), Scorpio
(acquired by US Robotics, then 3COM), DSPC (acquired by Intel),
DSPG (NASDAQ:DSPG), X Technologies (acquired by Guidant). The
fund’s capability in evaluating technologies combined
with its cumulative experience in venture capital, operations,
investments and M&A, create the foundation of Giza’s
vision and success.
www.giza.co.il
Star Ventures
Star Ventures (STAR) is an international venture capital fund
that invests in early-stage high-tech companies in Israel, the
United States and Germany/Europe. STAR focuses on companies
that are already active internationally or are preparing to
establish international business activities. Star Ventures has
approximately US$980 million under management in over 15 funds,
and has invested in 168 companies with more than 50 exits through
IPO’s or trade sales. Investment targets include information
technology, enterprise software, industrial technology and life
science companies. Star Ventures is headquartered in Munich,
Germany, with offices in Herzlia, Israel and Dallas, Texas,
USA. www.star-ventures.com
Hadasit Ltd.
Hadasit was established as a subsidiary of Hadassah Medical
Organization (HMO) in Jerusalem, Israel for the purpose of promoting
and commercializing its continuously generated intellectual
property (IP), aimed at finding solutions to problems faced
by modern medicine. IP generated by HMO has already gained a
place of honor in the international medical research arena with
cutting-edge biomedical technology for the development of novel
therapeutics, diagnostic methods and devices. Hadasit's ultimate
responsibility is to guide technologies from innovation to commercial
application. In order to accomplish this transformation, Hadasit
is equipped with the full-spectrum of resources and capabilities
required for composing and conducting the “symphony”
of pre-clinical services & clinical studies, establishing
start-up companies, offering product licensing and providing
international consulting services.
www.hadasit.co.il
Jerusalem Development Authority
The Jerusalem Development Authority (JDA) was established in
1988 as a joint government/municipal corporation under the authority
of the Israeli Minister of Finance, the Minister for Jerusalem
Affairs and the Mayor of Jerusalem. The JDA has a council made
up of 37 members, most of whom are representatives of the government
(public sector employees), the municipality (elected officials
and employees) and the public. Its many varied functions include
initiating activities and preparing plans for the economic development
of Jerusalem; coordinating between government ministries, authorities
and bodies dealing with the development of Jerusalem; and providing
information, advising and assisting in all matters connected
with the planning and establishment of economic enterprises
in Jerusalem.
www.jda.gov.il
|
 |
|
|
